682. [Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].
来源: Nihon Rinsho. 2016年74 Suppl 5卷565-9页
683. [The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].
来源: Nihon Rinsho. 2016年74 Suppl 5卷561-4页
684. [Cytogenetic and molecular prognostic factors for multiple myeloma].
来源: Nihon Rinsho. 2016年74 suppl 5卷283-7页
685. [FISH (fluorescence in situ hybridization) and SKY (spectral karyotyping)].
来源: Nihon Rinsho. 2016年74 Suppl 5卷234-9页
686. [Chromosomal abnormalities in plasma cell myeloma].
来源: Nihon Rinsho. 2016年74 Suppl 5卷227-33页
687. [Impact of TAK-1 inhibition on tumor growth and bone destruction in myeloma].
来源: Nihon Rinsho. 2016年74 Suppl 5卷185-9页
688. [Wnt signal inhibitors against multiple myeloma].
来源: Nihon Rinsho. 2016年74 Suppl 5卷173-9页
689. [Role of PARP1 in a development of multiple myeloma].
来源: Nihon Rinsho. 2016年74 Suppl 5卷168-72页
690. [Epigenetic dysregulation in multiple myeloma].
来源: Nihon Rinsho. 2016年74 Suppl 5卷163-7页
691. [Gene profiling using next generation sequence in multiple myeloma].
来源: Nihon Rinsho. 2016年74 Suppl 5卷148-51页
693. [Chromosomal abnormalities in multiple myeloma and myelomagenesis].
来源: Nihon Rinsho. 2016年74 Suppl 5卷132-6页
696. [Molecular biology of multiple myeloma: introduction].
来源: Nihon Rinsho. 2016年74 Suppl 5卷87-91页
697. [Inherited genetic susceptibility to MGUS and myeloma].
来源: Nihon Rinsho. 2016年74 Suppl 5卷73-6页
698. [Genetic polymorphisms in prostate cancer].699. [Basic research on the approach of the molecular pathology].
作者: Tomomi Fujii.;Keiji Shimada.;Yoshihiro Tatsumi.;Noboru Konishi.
来源: Nihon Rinsho. 2016年74 Suppl 3卷402-6页 700. [Pathology of the prostate cancer: present conditions and future prospects]. |